货号:AG-CR1-3725-M025 | 规格:25 mg | 目录价:¥360 |
货号:AG-CR1-3725-M100 | 规格:100 mg | 目录价:¥720 |
货号:AG-CR1-3725-M250 | 规格:250 mg | 目录价:¥2160 |
产品详情
* 以下信息仅供参考,详情请以原厂网站为准
产品名称:
Imatinib . mesylate
别名:
CGP-54148B; STI-571; Gleevec; Glivec
产品描述:
Imatinib mesylate is a multitarget tyrosine kinase inhibitor with antineoplastic activity. It is a potent and selective inhibitor of the kinases Bcr-Abl (IC50 = 38 nM), PDGFR and c-Kit, which are encoded by the bcr-abl oncogene as well as receptor tyrosine kinases encoded by c-Kit and platelet-derived growth factor receptor (PDGFR) oncogenes, which is useful in vitro and in vivo. Imatinib inhibits ligand-stimulated autophosphorylation of PDGFR and c-Kit and the proliferation of Bcr-Abl-dependent R10 cells and HMC-1 cells expressing constitutively active c-Kit in a concentration-dependent manner. Formulations containing imatinib have been used in the treatment of various cancers. Specifically, it is used for chronic myelogenous leukemia (CML) and acute lymphocytic leukemia (ALL) that are Philadelphia chromosome-positive (Ph+), certain types of gastrointestinal stromal tumors (GIST), hypereosinophilic syndrome (HES), chronic eosinophilic leukemia (CEL), systemic mastocytosis and myelodysplastic syndrome. Abelson (Abl) kinase inhibitors have been shown to inhibit replication of Ebola virus, coxsackievirus and vaccinia virus, but at different points of the virus life cycle. Imatinib inhibits replication of SARS-CoV and MERS-CoV in vitro by a novel mechanism of blocking coronavirus virion fusion with the endosomal membrane. Abl is also a potential drug target of SARS-CoV-2 and can possible inhibit the spread of COVID-19.
保存温度:
+4°C
运输温度:
Ambient
预期分子量:
493.6 . 96.1
产品形式:
solid
有效期:
Stable for at least 2 years after receipt when stored at -20°C.
产地:
瑞士
纯度:
>98% (HPLC)
CAS号:
220127-57-1
分子式:
C29H31N7O . CH4SO3
溶解度:
Soluble in water (30mg/ml) or DMSO (30mg/ml).
促销活动
精品推荐